Clinical trial
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
NCT06884514 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 3, 2025
- Completion date
- May 28, 2026
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy